Leaflet SUSTIVA 30mg / ml oral solution
Indicated for: HIV-1 infection
Route of administration: oral
Substance: efavirenz (non-nucleoside reverse transcriptase inhibitor)
ATC: J05AG03 (Antiinfectives for systemic use | Direct acting antivirals | Non-nucleoside reverse transcriptase inhibitors)
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Efavirenz is an antiretroviral medication used for the treatment of HIV-1 infection. It belongs to the class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) and works by blocking the enzyme necessary for HIV replication.
The medication is taken orally, usually once daily, in combination with other antiretroviral drugs, according to the doctor's instructions. It is effective in reducing viral load and increasing CD4 cell count.
Side effects may include dizziness, insomnia, rash, nausea, and, in rare cases, psychiatric disorders or hepatotoxicity. Regular monitoring is essential during treatment.
Consult your doctor to discuss the benefits and risks of treatment with Efavirenz. Follow the prescribed dosage and adhere to all medical recommendations.
General data about SUSTIVA 30mg / ml
- Substance: efavirenz
- Date of last drug list: 01-07-2013
- Commercial code: W51746001
- Concentration: 30mg / ml
- Pharmaceutical form: oral solution
- Quantity: 1
- Product type: original
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Pharmaceutical forms available for efavirenz
Concentrations available for efavirenz
- 100mg
- 200mg
- 300mg
- 30mg/ml
- 50mg
- 600mg